ABUS - Arbutus Biopharma Q1 2024 Earnings Preview
2024-05-01 11:46:16 ET
More on Arbutus Biopharma
- Moderna Investors Should Beware Patent-Dispute Fallout
- Arbutus Biopharma: The Markman Win Is A Good Milestone But Uncertainty Remains
- Arbutus Biopharma Corporation (ABUS) Q4 2023 Earnings Call Transcript
- Arbutus Biopharma jumps after claim construction order in patent fight with Moderna
- Arbutus Biopharma GAAP EPS of -$0.44 beats by $0.01, revenue of $18.1M misses by $3.04M